NCT02091882View on ClinicalTrials.gov

Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 21, 2014

Primary Completion Date

April 18, 2014

Study Completion Date

April 18, 2014

Conditions
Device Latency
Interventions
DRUG

Placebo

Oral placebo-embedded IEM tablet.

COMBINATION_PRODUCT

Combination product of Aripiprazole + IEM + Sensor + MIND1 Application

Combination product of aripiprazole tablet embedded with sensor and wearable patch with MIND1 system on smartphone

Trial Locations (1)

94598

Walnut Creek

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT02091882 - Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1) | Biotech Hunter | Biotech Hunter